References
- Friesner D, Rosenman R, Lobb BM, Tanne E. Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev 2011;12:e372-80. https://doi.org/10.1111/j.1467-789X.2010.00799.x
- Jensen RH, Radojicic A, Yri H. The diagnosis and management of idiopathic intracranial hypertension and the associated headache. Ther Adv Neurol Disord 2016;9:317-26. https://doi.org/10.1177/1756285616635987
- Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 2016;15:78-91. https://doi.org/10.1016/S1474-4422(15)00298-7
- Kesler A, Goldhammer Y, Gadoth N. Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases. J Neuroophthalmol 2001;21:15-7. https://doi.org/10.1097/00041327-200103000-00004
- Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry 2018;89:1088-100. https://doi.org/10.1136/jnnp-2017-317440
- Wang MTM, Bhatti MT, Danesh-Meyer HV. Idiopathic intracranial hypertension: pathophysiology, diagnosis and management. J Clin Neurosci 2022;95:172-9. https://doi.org/10.1016/j.jocn.2021.11.029
- Kilgore KP, Lee MS, Leavitt JA, et al. Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology 2017;124:697-700. https://doi.org/10.1016/j.ophtha.2017.01.006
- Miah L, Strafford H, Fonferko-Shadrach B, et al. Incidence, prevalence, and health care outcomes in idiopathic intracranial hypertension: a population study. Neurology 2021;96:e1251-61. https://doi.org/10.1212/WNL.0000000000011463
- Kesler A, Kliper E, Shenkerman G, Stern N. Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology 2010;117:169-74. https://doi.org/10.1016/j.ophtha.2009.06.030
- Hornby C, Mollan SP, Botfield H, O'Reilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol 2018;38:522-30. https://doi.org/10.1097/WNO.0000000000000684
- Andrews LE, Liu GT, Ko MW. Idiopathic intracranial hypertension and obesity. Horm Res Paediatr 2014;81:217-25. https://doi.org/10.1159/000357730
- Kim TW, Choung HK, Khwarg SI, Hwang JM, Yang HJ. Obesity may not be a risk factor for idiopathic intracranial hypertension in Asians. Eur J Neurol 2008;15:876-9. https://doi.org/10.1111/j.1468-1331.2008.02207.x
- World Health Organization (WHO). The Asia-Pacific perspective: redefining obesity and its treatment. Geneva: WHO; 2000.
- Haam JH, Kim BT, Kim EM, et al. Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr 2023;32:121-9. https://doi.org/10.7570/jomes23031
- Gafoor VA, Smita B, Jose J. Obesity, ethnicity and idiopathic intracranial hypertension. Ann Indian Acad Neurol 2019;22:352.
- Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 2010;341:c2701.
- Krajnc N, Itariu B, Macher S, et al. Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension. J Headache Pain 2023;24:89.
- Mollan SP, Mitchell JL, Ottridge RS, et al. Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol 2021;78:678-86. https://doi.org/10.1001/jamaneurol.2021.0659
- Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA 2014;311:1641-51. https://doi.org/10.1001/jama.2014.3312
- Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 2011;76:1564-7. https://doi.org/10.1212/WNL.0b013e3182190f51
- Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007;143:635-41. https://doi.org/10.1016/j.ajo.2006.12.040
- Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998;105:2313-7. https://doi.org/10.1016/S0161-6420(98)91234-9
- Nam GE, Kim YH, Han K, Jung JH, Rhee EJ, Lee WY. Obesity fact sheet in Korea, 2020: prevalence of obesity by obesity class from 2009 to 2018. J Obes Metab Syndr 2021;30:141-8. https://doi.org/10.7570/jomes21056
- Nam GE, Kim YH, Han K, et al. Obesity fact sheet in Korea, 2019: prevalence of obesity and abdominal obesity from 2009 to 2018 and social factors. J Obes Metab Syndr 2020;29:124-32. https://doi.org/10.7570/jomes20058
- Huh Y, Kim SH, Nam GE, Park HS. Weight gain, comorbidities, and its associated factors among Korean adults. J Korean Med Sci 2023;38:e90.